Challenges and opportunities of being a mid-size pharma player
All the news from Servier Group
Are incubators innovation boosters for start-up?
Research in rare diseases: a great potential for medical innovation for patients
Digital Twins: When AI drives progress for the pharmaceutical industry
New podcasts make patients’ voices heard
The collective challenge of climate change
Rare cancers and rare diseases: A common approach to treatment
THRPTX Innovation Summit: Servier to host its 1st international symposium
BiodiverCity® Label: Servier R&D Institute at Paris-Saclay, an Example to Follow